From: jeffrey E. <[email protected]> Sent: Friday, November 3, 2017 9:25 AM To: Masha Drokova Subject: Re: intrested in mony =br> On Fri, Nov 3, 2017 at 3:18 AM, Masha Drokov= wrote: what is investor type btw? =hat is one main quality for investor? <=iv>On Nov 2, 2017, at 9:53 PM, jeffrey E. <[email protected] <mailto:[email protected]» wrote: =/div> He is not an in=estor type . He is s partner at a firm but used to be at Microsoft. =ust use him for advice 11:13 PM Masha Drokova wrote: Thank you for=the comprehensive feedback Steven. For me the main value is that the system is a= order of magnitude cheaper than existing technologies, premised on levera=ing data to help users see what daily elements are affecting their blood s=gar, and predicting dangerous highs and lows before they happen so they ca= take actions beforehand. To date, their beta app has lowered blood sugar averages i= over 55% of users 2x better than the world's most prescribed diabetes=drug, Metformin. Which means that with the help of the date diabetes would=need to use less drugs. However I'd agree on complexity of regulations and satur=tion on the market. I run Day One Ve=tures fund and based in San Francisco. I'd be happy to connect in pers=n sometime to learn about about your experience and tell about our investm=nts and opportunities I see. wrote: O= Nov 2, 2017, at 3:24 PM, Steven Sinofsky Greetings Masha, I apologize for the delay. I was at some events in in=UK where I did not have connectivity. EFTA_R1_01741593 EFTA02572130